A 12-gene expression signature is associated with aggressive histological in prostate cancer: SEC14L1 and TCEB1 genes are potential markers of progression

American Journal of Pathology

Volumn 181, Issue 5, 2012, Pages 1585-1594

  Agell, Laia ^a,b   Hernández, Silvia ^c   Nonell, Lara ^a   Lorenzo, Marta ^a   Puigdecanet, Eulàlia ^a   De Muga, Silvia ^a,b   Juanpere, Nuria ^a,b   Bermudo, Raquel ^d,e   Fernández, Pedro L ^d,f   Lorente, José A ^a,b   Serrano, Sergio ^a,b   Lloreta, Josep ^a,c  

^a HOSPITAL DEL MAR   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c UNIVERSITAT POMPEU FABRA   (Spain)

^d INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^e INSTITUT DE BIOLOGIA MOLECULAR DE BARCELONA   (Spain)

^f UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; PROSTATE SPECIFIC ANTIGEN;

ARTICLE; CANCER GROWTH; CANCER PROGNOSIS; CONTROLLED STUDY; GENE; GENE EXPRESSION; GLEASON SCORE; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION;

ANALYSIS OF VARIANCE; CARRIER PROTEINS; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, NEOPLASM; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; NEOPLASM INVASIVENESS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION FACTORS; TRANSCRIPTOME; TUMOR MARKERS, BIOLOGICAL;

EID: 84868097948     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2012.08.005     Document Type: Article

References (42)

1. A. Cayuela, S. Rodriguez-Dominguez, V.E. Martin, B.R. Candau Recent changes in prostate cancer mortality in Spain: trends analysis from 1991 to 2005 Actas Urol Esp 32 2008 184 189
2. L. Kopper, J. Timar Genomics of prostate cancer: is there anything to "translate" Pathol Oncol Res 11 2005 197 203 (Pubitemid 43266921)
3. M.M. Shen, C. Abate-Shen Molecular genetics of prostate cancer: new prospects for old challenges Genes Dev 24 2010 1967 2000
4. A.M. Wolf, R.C. Wender, R.B. Etzioni, I.M. Thompson, A.V. D'Amico, R.J. Volk, D.D. Brooks, C. Dash, I. Guessous, K. Andrews, C. DeSantis, R.A. Smith American Cancer Society Prostate Cancer Advisory Committee American Cancer Society guideline for the early detection of prostate cancer: update 2010 CA Cancer J Clin 60 2010 70 98
5. J.T. Dong Prevalent mutations in prostate cancer J Cell Biochem 97 2006 433 447
6. J.A. Magee, T. Araki, S. Patil, T. Ehrig, L. True, P.A. Humphrey, W.J. Catalona, M.A. Watson, J. Milbrandt Expression profiling reveals hepsin overexpression in prostate cancer Cancer Res 61 2001 5692 5696 (Pubitemid 32769078)
7. J.B. Welsh, L.M. Sapinoso, A.I. Su, S.G. Kern, J. Wang-Rodriguez, C.A. Moskaluk, H.F. Frierson Jr, G.M. Hampton Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer Cancer Res 61 2001 5974 5978 (Pubitemid 32762523)
8. H. Chaib, E.K. Cockrell, M.A. Rubin, J.A. Macoska Profiling and verification of gene expression patterns in normal and malignant human prostate tissues by cDNA microarray analysis Neoplasia 3 2001 43 52 (Pubitemid 32201609)
9. J.H. Bull, G. Ellison, A. Patel, G. Muir, M. Walker, M. Underwood, F. Khan, L. Paskins Identification of potential diagnostic markers of prostate cancer and prostatic intraepithelial neoplasia using cDNA microarray Br J Cancer 84 2001 1512 1519 (Pubitemid 32579344)
10. A. Chetcuti, S. Margan, S. Mann, P. Russell, D. Handelsman, J. Rogers, Q. Dong Identification of differentially expressed genes in organ-confined prostate cancer by gene expression array Prostate 47 2001 132 140 (Pubitemid 32336583)
11. S.M. Dhanasekaran, T.R. Barrette, D. Ghosh, R. Shah, S. Varambally, K. Kurachi, K.J. Pienta, M.A. Rubin, A.M. Chinnaiyan Delineation of prognostic biomarkers in prostate cancer Nature 412 2001 822 826 (Pubitemid 32801464)
12. J.H. Luo, Y.P. Yu, K. Cieply, F. Lin, P. Deflavia, R. Dhir, S. Finkelstein, G. Michalopoulos, M. Becich Gene expression analysis of prostate cancers Mol Carcinog 33 2002 25 35 (Pubitemid 34052304)
13. R. Bermudo, D. Abia, B. Ferrer, I. Nayach, A. Benguria, A. Zaballos, J. del Rey, R. Miào, E. Campo, C. Martínez-A, A.R. Ortiz, P.L. Fernández, T.M. Thomson Co-regulation analysis of closely linked genes identifies a highly recurrent gain on chromosome 17q25.3 in prostate cancer BMC Cancer 8 2008 315
14. D.K. Vanaja, J.C. Cheville, S.J. Iturria, C.Y. Young Transcriptional silencing of zinc finger protein 185 identified by expression profiling is associated with prostate cancer progression Cancer Res 63 2003 3877 3882 (Pubitemid 36917897)
15. E. LaTulippe, J. Satagopan, A. Smith, H. Scher, P. Scardino, V. Reuter, W.L. Gerald Comprehensive gene expression analysis of prostate cancer reveals distinct transcriptional programs associated with metastatic disease Cancer Res 62 2002 4499 4506 (Pubitemid 34827314)
16. D. Singh, P.G. Febbo, K. Ross, D.G. Jackson, J. Manola, C. Ladd, P. Tamayo, A.A. Renshaw, A.V. D'Amico, J.P. Richie Gene expression correlates of clinical prostate cancer behavior Cancer Cell 1 2002 203 209 (Pubitemid 41039166)
17. J. Lapointe, C. Li, J.P. Higgins, M. van de Rijn, E. Bair, K. Montgomery, M. Ferrari, L. Egevad, W. Rayford, U. Bergerheim, P. Ekman, A.M. DeMarzo, R. Tibshirani, D. Botstein, P. Brown, J.D. Brooks, J.R. Pollack Gene expression profiling identifies clinically relevant subtypes of prostate cancer Proc Natl Acad Sci U S A 101 2004 811 816 (Pubitemid 38121040)
18. L. True, I. Coleman, S. Hawley, C.Y. Huang, D. Gifford, R. Coleman, T.M. Beer, E. Gelmann, M. Datta, E. Mostaghel, B. Knudsen, P. Lange, R. Vessella, D. Lin, L. Hood, P.S. Melson A molecular correlate to the gleason grading system for prostate adenocarcinoma Proc Natl Acad Sci U S A 103 2006 10991 10996 (Pubitemid 44148406)
19. A.E. Ross, L. Marchionni, M. Vuica-Ross, C. Cheadle, J. Fan, D.M. Berman, E.M. Schaeffer Gene expression pathways of high grade localized prostate cancer Prostate 2011 10.1002/pros.21373
20. R.A. Irizarry, B.M. Bolstad, F. Collin, L.M. Cope, B. Hobbs, T.P. Speed Summaries of Affymetrix GeneChip probe level data Nucleic Acids Res 31 2003 e15
21. G.K. Smyth Linear models and empirical bayes methods for assessing differential expression in microarray experiments Stat Appl Genet Mol Biol 3 2004 Article3
22. Y. Benjamini, Y. Hochberg Controlling the false discovery rate: a practical and powerful approach to multiple testing J R Stat Soc Series B Stat Methodol 57 1995 289 300
23. A. Subramanian, P. Tamayo, V.K. Mootha, S. Mukherjee, B.L. Ebert, M.A. Gillette, A. Paulovich, S.L. Pomeroy, T.R. Golub, E.S. Lander, J.P. Mesirov Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles Proc Natl Acad Sci U S A 102 2005 15545 15550 (Pubitemid 41528093)
24. R. Edgar, M. Domrachev, A.E. Lash Gene Expression Omnibus: NCBI gene expression and hybridization array data repository Nucleic Acids Res 30 2002 207 210 (Pubitemid 34679544)
25. L. Agell, S. Hernandez, M. Salido, S. de Muga, N. Juanpere, M. Arumi-Uria, S. Menendez, M. Lorenzo, J.A. Lorente, S. Serrano, J. Lloreta PI3K signaling pathway is activated by PIK3CA mRNA overexpression and copy gain in prostate tumors, but PIK3CA, BRAF, KRAS and AKT1 mutations are infrequent events Mod Pathol 24 2011 443 452
26. S. de Muga, S. Hernandez, L. Agell, M. Salido, N. Juanpere, M. Lorenzo, J.A. Lorente, S. Serrano, J. Lloreta Molecular alterations of EGFR and PTEN in prostate cancer: association with high-grade and advanced-stage carcinomas Mod Pathol 23 2010 703 712
27. N. Tsuchiya, J.M. Slezak, M.M. Lieber, E.J. Bergstralh, R.B. Jenkins Clinical significance of alterations of chromosome 8 detected by fluorescence in situ hybridization analysis in pathologic organ-confined prostate cancer Genes Chromosomes Cancer 34 2002 363 371 (Pubitemid 34787457)
28. F. Ohl, M. Jung, C. Xu, C. Stephan, A. Rabien, M. Burkhardt, A. Nitsche, G. Kristiansen, S.A. Loening, A. Radonic, K. Jung Gene expression studies in prostate cancer tissue: which reference gene should be selected for normalization J Mol Med 83 2005 1014 1024 (Pubitemid 41745760)
29. J. Vandesompele, K. De Preter, F. Pattyn, B. Poppe, N. Van Roy, A. De Paepe, F. Speleman Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes Genome Biol 3 2002 RESEARCH0034
30. J.D. Hoheisel Microarray technology: beyond transcript profiling and genotype analysis Nat Rev Genet 7 2006 200 210 (Pubitemid 43361531)
31. S.A. Tomlins, R. Mehra, D.R. Rhodes, X. Cao, L. Wang, S.M. Dhanasekaran, S. Kalyana-Sundaram, J.T. Wei, M.A. Rubin, K.J. Pienta, R.B. Shah, A.M. Chinnaiyan Integrative molecular concept modeling of prostate cancer progression Nat Genet 39 2007 41 51 (Pubitemid 46026500)
32. Y. Dong, E.A. Bey, L.S. Li, W. Kabbani, J. Yan, X.J. Xie, J.T. Hsieh, J. Gao, D.A. Boothman Prostate cancer radiosensitization through poly(ADP-ribose) polymerase-1 hyperactivation Cancer Res 70 2010 8088 8096
33. M.C. Haffner, A.M. De Marzo, A.K. Meeker, W.G. Nelson, S. Yegnasubramanian Transcription-induced DNA double strand breaks: both an oncogenic force and potential therapeutic target Clin Cancer Res 17 2011 3858 3864
34. S.D. Catz Characterization of Rab27a and JFC1 as constituents of the secretory machinery of prostate-specific antigen in prostate carcinoma cells Methods Enzymol 438 2008 25 40
35. U.V. Wesley, M. McGroarty, A. Homoyouni Dipeptidyl peptidase inhibits malignant phenotype of prostate cancer cells by blocking basic fibroblast growth factor signaling pathway Cancer Res 65 2005 1325 1334 (Pubitemid 40270159)
36. S.M. Henshall, L.G. Horvath, D.I. Quinn, S.A. Eggleton, J.J. Grygiel, P.D. Stricker, A.V. Biankin, J.G. Kench, R.L. Sutherland Zinc-alpha2- glycoprotein expression as a predictor of metastatic prostate cancer following radical prostatectomy J Natl Cancer Inst 98 2006 1420 1424 (Pubitemid 44530719)
37. P.Y. Yip, J.G. Kench, K.K. Rasiah, R.P. Benito, C.S. Lee, P.D. Stricker, S.M. Henshall, R.L. Sutherland, L.G. Horvath Low AZGP1 expression predicts for recurrence in margin-positive, localized prostate cancer Prostate 71 2011 1638 1645
38. S. Zhao, C. Xu, H. Qian, L. Lv, C. Ji, C. Chen, X. Zhao, D. Zheng, S. Gu, Y. Xie, Y. Mao Cellular retinaldehyde-binding protein-like (CRALBPL), a novel human Sec14p-like gene that is upregulated in human hepatocellular carcinomas, may be used as a marker for human hepatocellular carcinomas DNA Cell Biol 27 2008 159 163 (Pubitemid 351457768)
39. F.R. Ribeiro, C. Jeronimo, R. Henrique, D. Fonseca, J. Oliveira, R.A. Lothe, M.R. Teixeira 8q Gain is an independent predictor of poor survival in diagnostic needle biopsies from prostate cancer suspects Clin Cancer Res 12 2006 3961 3970 (Pubitemid 44078081)
40. O. Saramaki, T. Visakorpi Chromosomal aberrations in prostate cancer Front Biosci 12 2007 3287 3301
41. K. Porkka, O. Saramaki, M. Tanner, T. Visakorpi Amplification and overexpression of elongin C gene discovered in prostate cancer by cDNA microarrays Lab Invest 82 2002 629 637 (Pubitemid 34522375)
42. S.E. Jalava, K.P. Porkka, H.E. Rauhala, J. Isotalo, T.L. Tammela, T. Visakorpi TCEB1 promotes invasion of prostate cancer cells Int J Cancer 124 2009 95 102